Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
An accessible primer on stock index levels, detailing what they represent, how they’re calculated, and why they matter for portfolio assessment.
20,792 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Horizon Technology Finance slashes its monthly distribution to $0.06 per share, triggering a sharp stock selloff as f...
USA Rare Earth surged after a non-binding federal financing plan, igniting a Reddit-driven rally during ‘reddit loved...
Tesla unveils Terafab, a new in-house semiconductor fabrication unit focused on robotics and AI chips. Early signals ...
As the world leans harder on reliable, low-emission power, these nuclear energy stocks could offer compelling opportu...
Marathon Digital climbs as Bitcoin slides, buoyed by a strategic pivot into enterprise AI compute infrastructure and ...
Strategy reported a $12.54 billion Q1 loss driven by unrealized BTC declines, even as its software business expanded ...
Tesla isn’t just selling cars—it's building an autonomy and energy ecosystem. This piece examines whether tesla: wall...
Daiwa upgrades Qualcomm to Outperform, increasing the target to $225 as analysts forecast a broader AI infrastructure...
Amentum faces a pivotal Q2 2026 earnings season. This deep dive breaks down backlog, margins, and guidance, with prac...
Satellogic’s 2026 earnings hinge on a mix of recurring data licenses, expanding contracts, and efficient scaling. Thi...
Citi boosts its Intel price target to $130, arguing a new CPU TAM framework driven by agentic AI workloads positions ...